Advertisement News Archives - Page 1421 of 5245 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

November 16, 2026

AstraZeneca secures FDA approval for Imfinzi combo in MIBC

The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.

AstraZeneca secures FDA approval for Imfinzi combo in MIBC